Management of clandestine drug laboratories: Need for evidence-based environmental health policies

Environmental Health and Preventive Medicine

Volumn 19, Issue 1, 2014, Pages 1-11

  Al Obaidi, Tamara A ^a   Fletcher, Stephanie M ^b  

^a Independent Environmental Health Professional   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Australia; Clandestine drug laboratories; Environmental health practice; Evidence based policy; Research

Indexed keywords

ILLICIT DRUG; METHAMPHETAMINE;

AUSTRALIA; AUTHORITY; BIOREMEDIATION; CLANDESTINE DRUG LABORATORY; CLINICAL RESEARCH; CONTAMINATION; DRUG MANUFACTURE; ENVIRONMENTAL HEALTH; EVIDENCE BASED PRACTICE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; LABORATORY; LAW ENFORCEMENT; OCCUPATIONAL HEALTH; PRACTICE GUIDELINE; REVIEW;

AUSTRALIA; ENVIRONMENTAL HEALTH; HAZARDOUS SUBSTANCES; HEALTH POLICY; LABORATORIES; PUBLIC HEALTH; STREET DRUGS;

EID: 84893797341     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-013-0360-8     Document Type: Review

References (43)

1. Newell P. Clandestine drug manufacture in Australia. Chem Aust. 2008;75:11-4.
2. UNODC. World Drug Report 2010. New York: United Nations Office on Drugs and Crime (UNODC). 2010.
3. ACC. Illicit Drug Data Report 2010-11. Canberra City: Australian Crime Commission. 2012.
4. NDIC. Methamphetamine Laboratory Identification and Hazards: Fast Facts. National Drug Intelligence Center (NDIC), US Department of Justice. 2004.
5. Granholm JM, Olszewski J. Cleanup of Clandestine Drug Laboratory guidance. Michigan: Michigan Department of Community Health; 2007.
6. Martyny JW, Arbuckle SL, McCammon CS, Esswein EJ, Erb N, et al. Chemical concentrations and contamination associated with clandestine methamphetamine laboratories. J Chem Health Saf. 2007;1:40-52.
7. Salocks CB, Hui X, Lamel S, Qiao P, Sanborn JR, et al. Dermal exposure to methamphetamine hydrochloride contaminated residential surfaces: surface pH values, volatility, and in vitro human skin. Food Chem Toxicol. 2012;50:4436-40.
8. Environmental Risk Sciences. Derivation of risk-based investigation levels: Clandestine Drug Laboratory. Site Investigation Guidelines Australian Crime Commission. 2009.
9. VanDyke M, Erb N, Arbuckle S, Martyny J. A 24-hour study to investigate persistent chemical exposures associated with clandestine methamphetamine laboratories. J Occup Environ Hyg. 2009;6:82-9.
10. Bassindale T. Quantitative analysis of methamphetamine in hair of children removed from clandestine laboratories - evidence of passive exposure? Forensic Sci Int. 2012;219:179-82.
11. AGNMI. Clandestine drug laboratories 2012. Australia: Australian Government National Measurement Institute. 2012.
12. Cameron M. Health and safety concerns for law enforcement personnel investigating clandestine drug labs. Chem Health Saf. 2002;9:6-9.
13. ACC. Illicit Drug Data Report 2008-09. Canberra City: Australian Crime Commission. 2010.
14. ACC. Illicit Drug Data Report 2009-10. Canberra City: Australian Crime Commission. 2011.
15. Caldicott DGE, Pigou PE, Beattie R, Edwards JW. Clandestine drug laboratories in Australia and the potential for harm. Aust N Z J Public Health. 2005;29:155-62.
16. Barn P, Wiens M, Dods P. Clandestine amphetamine-derived drug laboratories: remediation guidelines for residential settings. 2012.
17. Smith JP (2011) Clandestine drug labs. Firehouse. Fort Atkinson, United States, Fort Atkinson: Cygnus Business Media, Inc. p. 22-29.
18. McKetin R, McLaren J, Kelly E. The Sydney methamphetamine market: patterns of supply, use, personal harms and social consequences. National Drug Law Enforcement Research Fund. 2005.
19. Cooper D, Souther L, Hanlon D, Fischer P, Leiker R, et al. Public health consequences among first responders to emergency events associated with illicit methamphetamine laboratories selected states, 1996-1999. Morb Mortal Wkly Rep. 2000;49:X-1024.
20. Cooper D, Rice N, Wilburn R, Horton DK, Rossiter S. Acute public health consequences of methamphetamine laboratories - 16 states, January 2000-June 2004. MMWR. 2005;54:356-9.
21. Melnikova N, Welles WL, Wilburn RE, Rice N, Wu J, et al. Hazards of illicit methamphetamine production and efforts at reduction: data from the hazardous substances emergency events surveillance system. Public Health Rep. 2011;126:116-23.
22. US EPA. Voluntary Guidelines for Methamphetamine Laboratory Cleanup. United States Environmental Protection Agency. 2013.
23. Welles WL, Wilburn RE, Ehrlich JK, Kamara JM. New York Hazardous Substances Emergency Events Surveillance (HSEES) data support emergency response, promote safety and protect public health. J Loss Prev Process Ind. 2009;22:728-34.
24. Cline JS. Illegal Methamphetamine Laboratories as a public health hazard. UNC School of Government. 2005.
25. Pal R, Megharaj M, Kirkbride KP, Naidu R. Illicit drugs and the environment. Hobart, Tasmania: National Drug Law Enforcement Research Fund (NDLERF). 978-0-9807169-4-8 978-0-9807169-4-8. 2008.
26. Pal R, Megharaj M, Kirkbride KP, Naidu R. Illicit drugs and the environment - a review. Sci Total Environ. 2012.
27. US DEA. Guidelines for law enforcement for the cleanup of clandestine drug laboratories Drug Enforcement Administration (US DEA) - U.S. Department of Justice. 2005.
28. Hannan D. Meth Labs (cover story). Prof Saf. 2005;50:24-31.
29. SOPHE. Helping Communities Combat Clandestine Methamphetamine Laboratories. The Society for Public Health Education (SOPHE) in conjunction with Agency for Toxic Substances and Disease Registry and The American College of Medical Toxicology. 2007.
30. Hammon TL, Griffin S. Support for selection of a methamphetamine cleanup standard in Colorado. Regul Toxicol Pharmacol. 2007;48:102-14.
31. Skeers VM. Illegal methamphetamine drug laboratories: a new challenge for environmental health professionals. J Environ Health. 1992;55:6-10.
32. Burgess JL, Barnhart S, Checkoway H. Investigating clandestine drug laboratories: adverse medical effects in law enforcement personnel. Am J Ind Med. 1996;30:488-94.
33. Burgess JL, Chandler D. Clandestine drug laboratories. Environ Toxicol. 646-665.
34. ADEC. Guidance and standards for cleanup of illegal drug-manufacturing sites. Alaska: Alaska Department of Environmental Conservation. 2007.
35. Horton D, Berkowitz Z, Kaye W. The acute health consequences to children exposed to hazardous substances used in illicit methamphetamine production, 1996-2001. J Child Health. 2003;1:99-108.
36. Witter RZ, Martyny JW, Mueller K, Gottschall B, Newman LS. Symptoms experienced by law enforcement personnel during methamphetamine lab investigations. J Occup Environ Hyg. 2007;4:895-902.
37. Australian National Drug Strategy. National Drug Strategy 2010-2015: a framework for action on alcohol, tobacco and other drugs. The National Drug Strategy. 2011.
38. Newell P, Hugel J, Vallely P, Wright J, Makin S, et al. Clandestine Drug Laboratory Remediation Guidelines. 2011.
39. Health WA. Clandestine drug laboratories. Western Australia: Western Australia-Department of Health; 2013.
40. WA Health. Interim Guidelines for Notification and Risk Management after Detection of a Clandestine Drug Laboratory (Clan Lab). Western Australia: Western Australia-Department of Health. 2012.
41. Victoria Department of Health. Clandestine Laboratory remediation: environmental health practice note. Victoria: Victoria Department of Health. 2012.
42. Queensland Health. Advice to owners of properties where an illicit drug laboratory has operated. Queensland Department of Health. 2012.
43. NCEPH. Australian Drug Markets Research: What are we doing? Where are we going? What are the gaps? In: Proceedings of a one-day workshop; 1993 Monday 22 February 1993; Scarth Room, University House, The Australian National University. National Centre for Epidemiology and Population Health (NCEPH).